Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eptacog alfa (activated) 1mg (50,000unit) inj pfs
0211000Z0AAAHAH
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj vials
0211000Z0AAADAD
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 240,000unit inj vials
0211000Z0AAACAC
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj pfs
0211000Z0AAAIAI
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj vials
0211000Z0AAAEAE
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj pfs
0211000Z0AAAJAJ
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj vials
0211000Z0AAAFAF
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 60,000unit inj vials
0211000Z0AAAAAA
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj pfs
0211000Z0AAAKAK
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj vials
0211000Z0AAAGAG
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 1mg (45,000unit) inj vials
0211000Z0AAALAL
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 2mg (90,000unit) inj vials
0211000Z0AAAMAM
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 5mg (225,000unit) inj vials
0211000Z0AAANAN
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptadone 1mg/ml oral solution
0410030C0BHABAA
|
Eptadone | Methadone hydrochloride | Central Nervous System | No data available |
|
Eptadone 5mg/ml oral solution
0410030C0BHAABM
|
Eptadone | Methadone hydrochloride | Central Nervous System | No data available |
|
Eptifibatide 20mg/10ml solution for injection vials
0209000X0AAAAAA
|
Eptifibatide | Eptifibatide | Cardiovascular System | No data available |
|
Eptifibatide 75mg/100ml solution for infusion vials
0209000X0AAABAB
|
Eptifibatide | Eptifibatide | Cardiovascular System | No data available |
|
Epysqli 300mg/30ml concentrate for inf vials
0901030M0BDAAAA
|
Epysqli | Eculizumab | Nutrition and Blood | No data available |
|
Equanox cylinders size AD
191500000BDBCA0
|
Proprietary compound preparation BNF 1915000 | Other gas preparations | Other Drugs and Preparations | No data available |
|
Equanox cylinders size AF4
191500000BDBBA0
|
Proprietary compound preparation BNF 1915000 | Other gas preparations | Other Drugs and Preparations | No data available |
|
Equanox cylinders size D
191500000BDBEA0
|
Proprietary compound preparation BNF 1915000 | Other gas preparations | Other Drugs and Preparations | No data available |
|
Equanox cylinders size F
191500000BDBKA0
|
Proprietary compound preparation BNF 1915000 | Other gas preparations | Other Drugs and Preparations | No data available |
|
Equanox cylinders size G
191500000BDBDA0
|
Proprietary compound preparation BNF 1915000 | Other gas preparations | Other Drugs and Preparations | No data available |
|
Equasym 10mg tablets
0404000M0BCABAA
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 20mg tablets
0404000M0BCACAK
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.